• Vorinostat (SAHA): Reliable HDAC Inhibition for Cancer Bi...

  2026-01-22

  This article guides biomedical researchers and lab technicians through real-world assay challenges, demonstrating how Vorinostat (SAHA, suberoylanilide hydroxamic acid) (SKU A4084) from APExBIO delivers reproducible, quantitative solutions in cell viability, apoptosis, and epigenetic studies. Scenario-driven Q&As address protocol optimization, data interpretation, and vendor selection, providing actionable insights for robust cancer biology research.

• Bay 11-7821: Precision IKK Inhibition for NF-κB Pathway R...

  2026-01-21

  Bay 11-7821 (BAY 11-7082) is a benchmark IKK inhibitor that empowers researchers to dissect NF-κB signaling with high specificity and reproducibility. Its unique solubility and dose-dependent performance make it indispensable for inflammatory signaling pathway research and apoptosis regulation studies in both cancer and immunology models.

• Rottlerin: Selective PKC Inhibitor for Advanced Cell Sign...

  2026-01-21

  Rottlerin stands out as a potent and selective PKCδ inhibitor, enabling researchers to unravel complex signaling pathways in cancer, virology, and endothelial biology. Its defined activity profile, robust in vitro and in vivo efficacy, and translational potential make it an indispensable tool for dissecting cell proliferation inhibition and apoptosis induction.

• ABT-888 (Veliparib): Potent PARP1/2 Inhibitor for Cancer ...

  2026-01-20

  ABT-888 (Veliparib) is a highly selective poly (ADP-ribose) polymerase (PARP) inhibitor that sensitizes cancer models—especially those with microsatellite instability—to chemotherapy and radiation. Its robust DNA repair inhibition profile and in vivo efficacy make it a reference tool for research in DNA damage response pathways.

454 records 31/31 page Previous First page 上5页 31